Author:
Grana Chiara Maria,Paganelli Giovanni
Reference68 articles.
1. Davis FG, Preston-Martin S. Epidemiology, incidence and survival in central nervous system neoplasia. In: Bigner DD, McLendon RE, Bruner JM, editors. Russell and Rubinstein’s pathology of tumors of the nervous system. 6th ed. London: Arnold; 1998. p. 5–145.
2. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002;359(9311):1011–8.
3. Wong ET, Hess KR, Gleason MJ, et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol. 1999;17(8): 2572–8.
4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2): 97–109.
5. Maher EA, Furnari FB, Bachoo RM, et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001;15(11):1311–33.